Showing results (31-40 of 344) with videos related to
Sort By:
Pageof 35
Scandinavian Journal of Immunology|November 1, 1989
Persistent superphosphorylation of leukosialin (CD43) in activated T cells and in tumour cell linesB Axelsson, P PerlmannScandinavian Journal of Immunology|January 1, 1975
Contamination of anti-immunoglobulin reagents with antibodies to beta 2-microglobulin and other unrelated antigens. Effects on immunofluorescence staining of human lymphocytesU Hellström, P PerlmannCytometry|July 1, 1984
The prognostic significance of DNA measurements in endometrial carcinomaB Moberger, G Auer, G Forsslund, et al.Acta Oto-Laryngologica|January 1, 1975
Squamous cell carcinoma of the gingiva. Histological classification and grading of malignancyR Willén, A Nathanson, G Moberger, et al.Folia Biologica|January 1, 1986
Immunotherapy of murine sarcomas with interleukin 2. II. Activation of killer cells by human recombinant IL-2M Indrová, J Bubeník, A ToulcováFolia Biologica|January 1, 1975
Tumour cell destruction by macrophages from conventional animalsV Holán, M Hasek, J BubeníkFolia Biologica|January 1, 1982
Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) testS Nĕmecková, J Bubeník, M IndrováActa Oncologica (Stockholm, Sweden)|January 1, 1990
The prognostic significance of growth pattern and its relation to tumor cell nuclear DNA content in endometrial carcinomaB Moberger, G Auer, N Einhorn, et al.Folia Biologica|January 1, 1992
Chemoimmunotherapy of cancer: cyclophosphamide-resistant tumour cells are equally sensitive as the original tumour cell population to local IL-2 immunotherapyJ Símová, J Bubeník, T JandlováImmunology Letters|February 1, 1990
Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2J Bubeník, J Símová, T JandlováPageof 35